Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes (vol 14, 118, 2015)

被引：0
|
作者：
Monnier, Vincent M. [1 ,2 ]
Sun, Wanjie [3 ]
Gao, Xiaoyu [3 ]
Sell, David R. [1 ]
Cleary, Patricia A. [3 ]
Lachin, John M. [3 ]
Genuth, Saul [4 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[3] George Washington Univ, Biostat Ctr, Rockville, MD USA
[4] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA
来源：
CARDIOVASCULAR DIABETOLOGY | 2015年 / 14卷
关键词：
D O I：
10.1186/s12933-015-0295-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 47 条
  • [21] Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
    Sveen, Kari Anne
    Dahl-Jorgensen, Knut
    Stensaeth, Knut Haakon
    Angel, Kristin
    Seljeflot, Ingebjorg
    Sell, David R.
    Monnier, Vincent M.
    Hanssen, Kristian F.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (03) : 407 - 412
  • [22] Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes -: Relevance of glycated collagen products versus HbA1c as markers of diabetic complications
    Monnier, VM
    Bautista, O
    Kenny, D
    Sell, DR
    Fogarty, J
    Dahms, W
    Cleary, PA
    Lachin, J
    Genuth, S
    DIABETES, 1999, 48 (04) : 870 - 880
  • [23] Higher plasma advanced glycation endproducts levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study
    Nin, J. W. M.
    Jorsal, A.
    Ferreira, I.
    Schalkwijk, C. G.
    Prins, M. H.
    Parving, H. -H.
    Tarnow, L.
    Rossing, P.
    Stehouwer, C. D. A.
    DIABETOLOGIA, 2010, 53 : S11 - S12
  • [24] Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 Diabetes
    Jiang, Guozhi
    Luk, Andrea O.
    Tam, Claudia H. T.
    Ozaki, Risa
    Lim, Cadmon K. P.
    Chow, Elaine Y. K.
    Lau, Eric S.
    Kong, Alice P. S.
    Fan, Baoqi
    Lee, Ka Fai
    Siu, Shing Chung
    Hui, Grace
    Tsang, Chiu Chi
    Lau, Kam Piu
    Leung, Jenny Y.
    Tsang, Man-wo
    Kam, Grace
    Lau, Ip Tim
    Li, June K.
    Yeung, Vincent T.
    Lau, Emmy
    Lo, Stanley
    Fung, Samuel
    Cheng, Yuk Lun
    Chow, Chun Chung
    Tang, Nelson L. S.
    Huang, Yu
    Lan, Hui-yao
    Oram, Richard A.
    Szeto, Cheuk Chun
    So, Wing Yee
    Chan, Juliana C. N.
    Ma, Ronald C. W.
    DIABETES, 2022, 71 (03) : 520 - 529
  • [25] Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes (vol 10, pg 18266, 2020)
    Scarinci, Fabio
    Picconi, Fabiana
    Virgili, Gianni
    Varano, Monica
    Giorno, Paola
    Frontoni, Simona
    Parravano, Mariacristina
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [26] 30-Year Cardiovascular Disease in Type 1 Diabetes: Risk and Risk Factors Differ by Long-term Patterns of Glycemic Control
    Miller, Rachel G.
    Orchard, Trevor J.
    Costacou, Tina
    DIABETES CARE, 2022, 45 (01) : 142 - 150
  • [27] The Cumulative Incidence of Advanced Renal Disease Affects over 70% of Those with Type 1 Diabetes with Long-Term Follow-Up
    Orchard, Trevor J.
    Costacou, Tina
    DIABETES, 2017, 66 : A81 - A81
  • [28] Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
    Holte, Kristine B.
    Svanteson, Mona
    Hanssen, Kristian F.
    Sveen, Kari Anne
    Seljeflot, Ingebjorg
    Solheim, Svein
    Sell, David R.
    Monnier, Vincent M.
    Berg, Tore Julsrud
    PLOS ONE, 2020, 15 (05):
  • [29] Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial
    Katakami, Naoto
    Mita, Tomoya
    Yoshii, Hidenori
    Shiraiwa, Toshihiko
    Yasuda, Tetsuyuki
    Okada, Yosuke
    Kurozumi, Akira
    Hatazaki, Masahiro
    Kaneto, Hideaki
    Osonoi, Takeshi
    Yamamoto, Tsunehiko
    Kuribayashi, Nobuichi
    Maeda, Kazuhisa
    Yokoyama, Hiroki
    Kosugi, Keisuke
    Ohtoshi, Kentaro
    Hayashi, Isao
    Sumitani, Satoru
    Tsugawa, Mamiko
    Ryomoto, Kayoko
    Kato, Ken
    Nakamura, Tadashi
    Kawashima, Satoshi
    Sato, Yasunori
    Watada, Hirotaka
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [30] Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial
    Naoto Katakami
    Tomoya Mita
    Hidenori Yoshii
    Toshihiko Shiraiwa
    Tetsuyuki Yasuda
    Yosuke Okada
    Akira Kurozumi
    Masahiro Hatazaki
    Hideaki Kaneto
    Takeshi Osonoi
    Tsunehiko Yamamoto
    Nobuichi Kuribayashi
    Kazuhisa Maeda
    Hiroki Yokoyama
    Keisuke Kosugi
    Kentaro Ohtoshi
    Isao Hayashi
    Satoru Sumitani
    Mamiko Tsugawa
    Kayoko Ryomoto
    Ken Kato
    Tadashi Nakamura
    Satoshi Kawashima
    Yasunori Sato
    Hirotaka Watada
    Iichiro Shimomura
    Cardiovascular Diabetology, 22
12345